Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Ovid Therapeutics Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 74 | 1 | 75 | +2 |
| Shares | 46.0M | 3.99M | 46.3M | +4.29M (+10.2%) |
| Value | $35.4M | $3.07M | $54.7M | +$22.3M (+69.1%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Ovid Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,314,437 | $5.09M | 0.00% |
| Siren, L.L.C. | 2,850,000 | $3.36M | 0.17% |
| Assenagon Asset Management S.A. | 86,289 | $101.8K | 0.00% |
| Verition Fund Management LLC | 74,875 | $88.4K | 0.00% |
| SG Americas Securities, LLC | 20,464 | $24.0K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 16,522 | $19.3K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 11,431 | $13.5K | 0.00% |
| Capital Performance Advisors LLP | 146 | $172 | 0.00% |
| Sterling Capital Management LLC | 61 | $72 | 0.00% |
| TD Waterhouse Canada Inc. | 30 | $34 | 0.00% |
Sold out (8)
Institutions that held Ovid Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 2,500,000 | $1.92M |
| FFT Wealth Management LLC | 489,552 | $376.6K |
| Wellington Management Group LLP | 115,832 | $89.1K |
| Millennium Management LLC | 78,024 | $60.0K |
| Knott David M Jr | 20,000 | $15.0K |
| Two Sigma Investments, LP | 12,628 | $9.71K |
| Baader Bank INC | 13,282 | $8.32K |
| Federated Hermes, Inc. | 2,250 | $1.73K |
Not filed for Q3 2024 yet (1)
Institutions that held Ovid Therapeutics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,992,346 | $3.07M |